Phagenesis raises $42m series D led by EQT Life Sciences and Sectoral Asset Management, w/ British Patient Capital, Northern Gritstone and Aphelion

Health services Pharma

United Kingdom

Sweden

United States

Canada

Investments

27 February 2024

Share:

Phagenesis (company)

United Kingdom

Health services Pharma

Total investments received (USD): 42m

Round value (USD): 42m

Round investors: EQT Partners British Patient Capital Northern Gritstone Aphelion Capital Sectoral Asset Management

Company: Phagenesis

Industry: Health services Pharma

Related deals

Manual raised £29.2m with Felix Capital, Cherry Ventures, alongside new investor Octopus Ventures.

Beauty Ecommerce Health services Mobile Pharma

United Kingdom

Germany

United States

Investments 16 June 2024

Yellowstone Biosciences raises £16.5M with Syncona Partners

Biotech Health services Pharma

United Kingdom

Investments 13 June 2024

Theolytics raised £19m in funding from Sound Bioventures, M Ventures, Taiho Ventures, Epidarex Capital, Oxford Science Enterprises.

Biotech Health services Pharma

United Kingdom

United States

Netherlands

Japan

Sweden

Investments 07 April 2024

Relation Therapeutics raises $35 million seed extension from NVentures, DCVC, Deerfield Management, Khosla Ventures, ARK Invest and Magnetic Ventures.

Biotech Health services Manufacturing Pharma

United Kingdom

United States

Investments 04 March 2024

Enterprise Therapeutics to raise £26M series B with Panakes Partners, Versant Ventures, Novartis Venture Fund, IP Group, Forbion Capital, Epidarex Capital

Health services Manufacturing Pharma

United Kingdom

United States

Netherlands

Switzerland

Italy

Investments 04 January 2024